Screening of Key Biomarkers and Immune Infiltration in Pulmonary Arterial Hypertension Via Integrated Bioinformatics Analysis

Overview

Journal Bioengineered

Date 2021 Jul 8

PMID 34233597

Citations 9

Authors

Yu Zeng

Nanhong Li

Zhenzhen Zheng

Riken Chen

Wang Liu

Junfen Cheng

Jinru Zhu

Mingqing Zeng

Min Peng

Cheng Hong

Affiliations

Soon will be listed here.

Abstract

This study aimed to screen key biomarkers and investigate immune infiltration in pulmonary arterial hypertension (PAH) based on integrated bioinformatics analysis. The Gene Expression Omnibus (GEO) database was used to download three mRNA expression profiles comprising 91 PAH lung specimens and 49 normal lung specimens. Three mRNA expression datasets were combined, and differentially expressed genes (DEGs) were obtained. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses and the protein-protein interaction (PPI) network of DEGs were performed using the STRING and DAVID databases, respectively. The diagnostic value of hub gene expression in PAH was also analyzed. Finally, the infiltration of immune cells in PAH was analyzed using the CIBERSORT algorithm. Total 182 DEGs (117 upregulated and 65 downregulated) were identified, and 15 hub genes were screened. These 15 hub genes were significantly associated with immune system functions such as myeloid leukocyte migration, neutrophil migration, cell chemotaxis, Toll-like receptor signaling pathway, and NF-κB signaling pathway. A 7-gene-based model was constructed and had a better diagnostic value in identifying PAH tissues compared with normal controls. The immune infiltration profiles of the PAH and normal control samples were significantly different. High proportions of resting NK cells, activated mast cells, monocytes, and neutrophils were found in PAH samples, while high proportions of resting T cells CD4 memory and Macrophages M1 cell were found in normal control samples. Functional enrichment of DEGs and immune infiltration analysis between PAH and normal control samples might help to understand the pathogenesis of PAH.

Citing Articles

Exploring the Anti-PANoptosis Mechanism of Dachaihu Decoction Against Sepsis-Induced Acute Lung Injury: Network Pharmacology, Bioinformatics, and Experimental Validation.

Yang Z, Kao X, Zhang L, Huang N, Chen J, He M Drug Des Devel Ther. 2025; 19():349-368.

PMID: 39839500 PMC: 11750123. DOI: 10.2147/DDDT.S495225.

Unveiling Immune-related feature genes for Alzheimer's disease based on machine learning.

Zhang G, Sun S, Wang Y, Zhao Y, Sun L Front Immunol. 2024; 15:1333666.

PMID: 38915415 PMC: 11194375. DOI: 10.3389/fimmu.2024.1333666.

Identification of monocyte-associated pathways participated in the pathogenesis of pulmonary arterial hypertension based on omics-data.

Zhong C, Si Y, Yang H, Zhou C, Chen Y, Wang C Pulm Circ. 2023; 13(4):e12319.

PMID: 38130888 PMC: 10733707. DOI: 10.1002/pul2.12319.

Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4-Human Leukocyte Antigen-DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension.

Hafeez N, Kirillova A, Yue Y, Rao R, Kelly N, El Khoury W J Am Heart Assoc. 2023; 12(7):e027894.

PMID: 36974749 PMC: 10122886. DOI: 10.1161/JAHA.122.027894.

Construction of a diagnostic signature and immune landscape of pulmonary arterial hypertension.

Duo M, Liu Z, Zhang Y, Li P, Weng S, Xu H Front Cardiovasc Med. 2022; 9:940894.

PMID: 36531729 PMC: 9751874. DOI: 10.3389/fcvm.2022.940894.

References

Meloche J, Courchesne A, Barrier M, Carter S, Bisserier M, Paulin R . Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. J Am Heart Assoc. 2013; 2(1):e005157. PMC: 3603259. DOI: 10.1161/JAHA.112.005157. View

Shlyonsky V, Naeije R, Mies F . Possible role of lysophosphatidic acid in rat model of hypoxic pulmonary vascular remodeling. Pulm Circ. 2015; 4(3):471-81. PMC: 4278607. DOI: 10.1086/677362. View

Cai W, Li H, Zhang Y, Han G . Identification of key biomarkers and immune infiltration in the synovial tissue of osteoarthritis by bioinformatics analysis. PeerJ. 2020; 8:e8390. PMC: 6970550. DOI: 10.7717/peerj.8390. View

DAlonzo G, Barst R, Ayres S, Bergofsky E, Brundage B, Detre K . Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991; 115(5):343-9. DOI: 10.7326/0003-4819-115-5-343. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Farha S, Dweik R, Rahaghi F, Benza R, Hassoun P, Frantz R . Imatinib in pulmonary arterial hypertension: c-Kit inhibition. Pulm Circ. 2015; 4(3):452-5. PMC: 4278604. DOI: 10.1086/677359. View

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

Benza R, Miller D, Barst R, Badesch D, Frost A, McGoon M . An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest. 2012; 142(2):448-456. DOI: 10.1378/chest.11-1460. View

McCormick M, Rahimi F, Bobryshev Y, Gaus K, Zreiqat H, Cai H . S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem. 2005; 280(50):41521-9. DOI: 10.1074/jbc.M509442200. View

10.

Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A . Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. N Engl J Med. 2021; 384(4):325-334. DOI: 10.1056/NEJMoa2008470. View

11.

Vogl T, Stratis A, Wixler V, Voller T, Thurainayagam S, Jorch S . Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation. J Clin Invest. 2018; 128(5):1852-1866. PMC: 5919817. DOI: 10.1172/JCI89867. View

12.

Johnson W, Li C, Rabinovic A . Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2006; 8(1):118-27. DOI: 10.1093/biostatistics/kxj037. View

13.

von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B . STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003; 31(1):258-61. PMC: 165481. DOI: 10.1093/nar/gkg034. View

14.

Harris M, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R . The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2003; 32(Database issue):D258-61. PMC: 308770. DOI: 10.1093/nar/gkh036. View

15.

Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

16.

Zhao X, Bai X, Li J, Li S, Xi J . Sevoflurane improves circulatory function and pulmonary fibrosis in rats with pulmonary arterial hypertension through inhibiting NF-κB signaling pathway. Eur Rev Med Pharmacol Sci. 2019; 23(23):10532-10540. DOI: 10.26355/eurrev_201912_19694. View

17.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

18.

Li C, Liu P, Song R, Zhang Y, Lei S, Wu S . Immune cells and autoantibodies in pulmonary arterial hypertension. Acta Biochim Biophys Sin (Shanghai). 2017; 49(12):1047-1057. DOI: 10.1093/abbs/gmx095. View

19.

Liu J, Wan Y, Li S, Qiu H, Jiang Y, Ma X . Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis. Cancer Med. 2020; 9(10):3522-3536. PMC: 7221444. DOI: 10.1002/cam4.2956. View

20.

Machado R, Aldred M, James V, Harrison R, Patel B, Schwalbe E . Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat. 2006; 27(2):121-32. DOI: 10.1002/humu.20285. View